Tuesday, January 12, 2016 6:03:24 PM
Published on Jan 12, 2016
Chronic pain results from central sensitization, which causes the nervous system to develop a persistent state of high reactivity. This serves to amplify and maintain the pain even after the initial injury has healed.
Therefore, chronic pain is often poorly correlated to the degree of peripheral tissue injury. ActiPatch’s electromagnetic signal pulses 1,000 times per second to stimulate neuromodulation of the afferent nerves to dampen the brains perception of pain.
The ActiPatch® pulsed signal rate prevents adaption to allow long-term use. ActiPatch® therapy extended pain relief improves sleep, physical activity and overall quality of life.
The ActiPatch® works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more. ActiPatch® is drug and ingredient-free so is safe for continuous use and can be used while taking any other medication. Unlike a TENS machine, you will not feel heat or vibration. In fact, ActiPatch® is completely sensation free, so the only thing you are going to feel is better.
Learn more at www.bielcorp.com/technology
Video presented by Kenneth McLeod, Ph.D. (Bioengineering Consultant to BioElectronics Corporation)
Category
Science & Technology
License
Standard YouTube License
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM